The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
Open accessAbstract
Among new biological markers that could become useful prognostic factors for lung carcinoma, Ki-67 is a nuclear protein involved in cell proliferation regulation. Some studies have suggested an association between Ki-67 and poor survival in lung cancer patients. In order to clarify this point, we have performed a systematic review of the literature, using the methodology already described by our Group, the European Lung Cancer Working Party. In total, 37 studies, including 3983 patients, were found to be eligible. In total, 49% of the patients were considered as having a tumour positive for the expression of Ki-67 according to the authors cutoff. In all, 29 of the studies dealt with non-small-cell lung carcinoma (NSCLC), one with small-cell carcinoma (SCLC), two with carcinoid tumours and five with any histology. In terms of survival results, Ki-67 was a bad prognosis factor for survival in 15 studies while it was not in 22. As there was no statistical difference in quality scores between the significant and nonsignificant studies evaluable for the meta-analysis, we were allowed to aggregate the survival results. The combined hazard ratio for NSCLC, calculated using a random-effects model was 1.56 (95% CI: 1.30-1.87), showing a worse survival when Ki-67 expression is increased. In conclusion, our meta-analysis shows that the expression of Ki-67 is a factor of poor prognosis for survival in NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“The individual HR estimated were combined into an overall HR using the method published by Peto (Yusuf et al, 1985).”
MethodG 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Aupérin, A., Arriagada, R., Pignon, J.-P., Le Péchoux, C., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,718
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Language bias in randomised controlled trials published in English and German
Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02419-7 · Cited by 1,028
Gerdes, J., Li, L., Schlueter, C. J., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., & Flad, H. D. (1991) · PubMed · Cited by 889
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856 · cited 1×
“The first approach is based on fully published data and provides an exhaustive and critical analysis on the topic with an adequate methodology based on the criteria of Mulrow (1987).”
MethodMeta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
Dominoes and Clocks: the Union of Two Views of the Cell Cycle
Murray, A. W., & Kirschner, M. W. (1989) · Science · doi:10.1126/science.2683077 · Cited by 729
Review: assessment of cell proliferation in histological material.
Hall, P. A., & Levison, D. A. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.3.184 · Cited by 437
Steels, E., Paesmans, M., Berghmans, T., Branle, F., Lemaitre, F., Mascaux, C., Meert, A. P., Vallot, F., Lafitte, J. J., & Sculier, J. P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00062201 · Cited by 418
Self-citationHistopathologic Grading of Ovarian Carcinoma: A Review and Proposal
Silverberg, S. G. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200001000-00003 · Cited by 351
Harpole, D. H., Herndon, J. E., Wolfe, W. G., Iglehart, J. D., & Marks, J. R. (1995) · PubMed · Cited by 290
Meert, A.-P., Paesmans, M., Berghmans, T., Martin, B., Mascaux, C., Vallot, F., Verdebout, J.-M., Lafitte, J.-J., & Sculier, J.-P. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-5 · Cited by 281
Self-citationMascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J. J., Lemaı̂tre, F., Meert, A. P., Vermylen, P., & Sculier, J. P. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00127-6 · Cited by 270
Self-citationMeert, A.-P., Martin, B., Delmotte, P., Berghmans, T., Lafitte, J.-J., Mascaux, C., Paesmans, M., Steels, E., Verdebout, J.-M., & Sculier, J.-P. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00296502 · Cited by 264
Self-citationMeert, A.-P., Paesmans, M., Martin, B., Delmotte, P., Berghmans, T., Verdebout, J.-M., Lafitte, J.-J., Mascaux, C., & Sculier, J.-P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600551 · Cited by 241
Self-citationD'Amico, M., Massey, M., Herndon II, P., Moore, M.-B., & Harpole, D. H. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70294-1 · Cited by 233
Method for grading breast cancer.
Elston, E. W., & Ellis, I. O. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.2.189-b · Cited by 201
Spyratos, F., Ferrero‐Poüs, M., Trassard, M., Hacène, K., Phillips, E., Tubiana‐Hulin, M., & Le Doussal, V. (2002) · Cancer · doi:10.1002/cncr.10458 · Cited by 186
Tubiana, M., & Courdi, A. (1989) · Radiotherapy and Oncology · doi:10.1016/0167-8140(89)90113-8 · Cited by 176
Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung
Pelosi, G., Fraggetta, F., Pasini, F., Maisonneuve, P., Sonzogni, A., Iannucci, A., Terzi, A., Bresaola, E., Valduga, F., Lupo, C., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200103000-00011 · Cited by 175
PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER
GIATROMANOLAKI, A., KOUKOURAKIS, M., O'BYRNE, K., FOX, S., WHITEHOUSE, R., TALBOT, D. C., HARRIS, A. L., & GATTER, K. C. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199605)179:1<80::aid-path547>3.0.co;2-x · Cited by 169
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
Lee, J. S., Yoon, A., Kalapurakal, S. K., Ro, J. Y., Lee, J. J., Tu, N., Hittelman, W. N., & Hong, W. K. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.1893 · Cited by 163
Martin, B., Paesmans, M., Berghmans, T., Branle, F., Ghisdal, L., Mascaux, C., Meert, A.-P., Steels, E., Vallot, F., Verdebout, J.-M., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601095 · Cited by 163
Self-citationAngiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer
Harpole, D. H., Richards, W. G., Herndon, J. E., & Sugarbaker, D. J. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00104-x · Cited by 128
Ferreira, C. G., van der Valk, P., Span, S. W., Ludwig, I., Smit, E. F., Kruyt, F. A. E., Pinedo, H. M., van Tinteren, H., & Giaccone, G. (2001) · PubMed · Cited by 126
Meert, A., Martin, B., Paesmans, M., Berghmans, T., Mascaux, C., Verdebout, J., Delmotte, P., Lafitte, J.-J., & Jp, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601252 · Cited by 111
Self-citationPrognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
Hommura, F., Dosaka‐Akita, H., Mishina, T., Nishi, M., Kojima, T., Hiroumi, H., Ogura, S., Shimizu, M., Katoh, H., & Kawakami, Y. (2000) · PubMed · Cited by 110
Dingemans, A. C., Witlox, A. M. A., Stallaert, R. A. L. M., van der Valk, P., Postmus, P. E., & Giaccone, G. (1999) · PubMed · Cited by 109
Ishida, H., Irie, K., Itoh, T., Furukawa, T., & Tokunaga, O. (1997) · Cancer · Cited by 101
Typical and atypical bronchopulmonary carcinoid tumors: A clinicopathologic and Kl-67-labeling study
Costes, V., Marty-Ané, C. H., Picot, M., Serre, I., Pujol, J.-L., Mary, H., & Baldet, P. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90221-x · Cited by 99
Ki‐67 immunostaining and survival in operable lung cancer
Tungekar, M. F., Gatter, K. C., Dunnill, M. S., & Mason, D. Y. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb01503.x · Cited by 86
Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens
Rudolph, P., Peters, J., Lorenz, D., Schmidt, D., & Parwaresch, R. M. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90248-9 · Cited by 77
Prognostic Significance of the Proliferation Index in Surgically Resected Non—Small-Cell Lung Cancer
Pence, J. C. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420240090017 · Cited by 76
Minami, K.-I., Saito, Y., Imamura, H., & Okamura, A. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00108-3 · Cited by 73
Shiba, M., Kohno, H., Kakizawa, K., Iizasa, T., Otsuji, M., Saitoh, Y., Hiroshima, K., Ohwada, H., & Fujisawa, T. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1457::aid-cncr7>3.0.co;2-l · Cited by 72
Nguyen, V. N., Mirejovský, P., Miejovský, T., Melínová, L., & Mandys, V. (2000) · Acta Histochemica · doi:10.1078/s0065-1281(04)70039-2 · Cited by 65
Demarchi, L. M. M. F., Reis, M. M., Palomino, S. A. P., Farhat, C., Takagaki, T. Y., Beyruti, R., Saldiva, P. H. N., & Capelozzi, V. L. (2000) · Modern Pathology · doi:10.1038/modpathol.3880089 · Cited by 62
Lehr, H., Hansen, D. A., Kussick, S. J., Li, M., Hwang, H., Krummenauer, F., Trouet, S., & Gown, A. M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90062-x · Cited by 46
Sculier, J. P., Ghisdal, L., Berghmans, T., Branle, F., Lafitte, J. J., Vallot, F., Meert, A. P., Lemaitre, F., Steels, E., Burniat, A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1742 · Cited by 37
Self-citationPrognostic Biomarker Study in Pathologically Staged N1 Non-Small Cell Lung Cancer
Komaki, R. U., Milas, L., Ro, J. Y., Fujii, T., Perkins, P., Allen, P. K., Sikes, C. R., Mountain, C. F., & Ordóǹez, N. G. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00898-5 · Cited by 33
Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Chinè, S., Angeletti, C. A., & Bevilacqua, G. (1996) · PubMed · Cited by 30
Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti, M., Elsner, B., Paez De Lima, A., Esteva, H., & Marchevsky, A. M. (1997) · PubMed · Cited by 28
[Ki-67 antigen, a cell cycle and tumor growth marker].
Seigneurin, D., & Guillaud, P. (1991) · PubMed · Cited by 27
Meert, A., Berghmans, T., Branle, F., Lemaître, F., Mascaux, C., Rubesova, E., Vermylen, P., Paesmans, M., & Sculier, J. (1999) · PubMed · Cited by 22
Self-citation
Cited by
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationKi67 is a promising molecular target in the diagnosis of cancer (Review)
LI, L. T., JIANG, G., CHEN, Q., & ZHENG, J. N. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2914 · Cited by 859
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yatabe, Y., Dacic, S., Borczuk, A. C., Warth, A., Russell, P. A., Lantuejoul, S., Beasley, M. B., Thunnissen, E., Pelosi, G., Rekhtman, N., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.005 · Cited by 365
Sculier, J.-P., Chansky, K., Crowley, J. J., Van Meerbeeck, J., & Goldstraw, P. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31816de2b8 · Cited by 337
Self-citationVesselle, H., Salskov, A., Turcotte, E., Wiens, L., Schmidt, R., Jordan, C. D., Vallières, E., & Wood, D. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818307a7 · Cited by 165
Metadata
- Authors
- Martin, B., Paesmans, M., Mascaux, C., Berghmans, T., Lothaire, P., Meert, A.-P., Lafitte, J.-J., & Sculier, J.-P.
- Venue
- British Journal of Cancer
- Published
- 2004-11-16
- Volume
- 91
- Issue
- 12
- Pages
- 2018-2025
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2067757569
- Cited by
- 277
- References
- 48
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.